<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-Y1ZULDIG</identifier><date>2012 2009/04 05</date><relation>documents/doc/Y/URN_NBN_SI_doc-Y1ZULDIG_001.htm</relation><relation>documents/doc/Y/URN_NBN_SI_doc-Y1ZULDIG_001.pdf</relation><relation>documents/doc/Y/URN_NBN_SI_doc-Y1ZULDIG_001.txt</relation><relation>documents/doc/Y/URN_NBN_SI_doc-Y1ZULDIG_001.xml</relation><format format_type="type">Aplikativni projekti</format><identifier identifier_type="URN">URN:NBN:SI:doc-Y1ZULDIG</identifier><language>slv</language><publisher>Kemijski inštitut</publisher><publisher>Lek farmacevtska družba d.d.</publisher><source>Zaključna poročila ARRS</source><rights>InC</rights><title>Aplikativni projekt</title><title>Razvoj novih oblik nanodelcev TNF-alfa za uporabo v terapiji</title></Record>